Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interest
Beginning Balance at Dec. 31, 2020	[1]	$ 30,611	$ 164	$ 417,855	$ (387,408)	$ 0
Beginning Balance, Shares at Dec. 31, 2020	[1]		164,063,787
Net loss attributable to Alignment Healthcare, Inc.		(56,874)	$ 0	0	(56,874)	0
Issuance of common stock, net of issuance costs		361,601	$ 22	361,579	0	0
Issuance of common stock, net of issuance costs, Shares			21,700,000
Issuance of common stock to third-party business partners		6,480	$ 1	6,479	0	0
Issuance of common stock to third-party business partners, Shares			573,782
Issuance of common stock to stock appreication rights holders		11,510	$ 1	11,509	0	0
Issuance of common stock to stock appreication rights holders, Shares			936,213
Equity-based compensation		2,398	$ 0	2,398	0	0
Equity repurchase		(1,474)	0	1,474	0	0
Ending Balance at Mar. 31, 2021		354,252	$ 188	798,346	(444,282)	0
Ending Balance, Shares at Mar. 31, 2021			187,273,782
Beginning Balance at Dec. 31, 2021		$ 306,055	$ 187	888,547	(582,694)	15
Beginning Balance, Shares at Dec. 31, 2021		187,193,613	187,193,613
Net loss attributable to Alignment Healthcare, Inc.		$ (40,817)	$ 0	0	(40,817)	0
Issuance of common stock upon vesting of restricted stock units			383,508
Forfeitures		0	$ 0	0	0	0
Forfeitures, shares			(163,064)
Equity-based compensation		28,047		28,047	0	0
Ending Balance at Mar. 31, 2022		$ 293,285	$ 187	$ 916,594	$ (623,511)	$ 15
Ending Balance, Shares at Mar. 31, 2022		187,414,057	187,414,057

[1] The consolidated balances as of December 31, 2020 were derived from the audited consolidated financial statements as of that date and were retroactively adjusted, including shares and per share amounts, as a result of the Reorganization. See Note 1 to the condensed consolidated financial statements for additional details.